Anti-hypertensive treatment and serum lipids.
Slaiman
S
S
D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D006951:Hyperlipoproteinemias / Q000139:chemically induced*; D006973:Hypertension / Q000097:blood / Q000188:drug therapy*; D008075:Lipoproteins, HDL / Q000097:blood*; D008077:Lipoproteins, LDL / Q000097:blood*; D011437:Propylamines / Q000627:therapeutic use*; D012107:Research Design; D013976:Tiapamil Hydrochloride
D000959:Antihypertensive Agents; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D011437:Propylamines; D013976:Tiapamil Hydrochloride